Hyperlipidemia lifestyle modifications

Provide patient education in regard to CHD, hyperlipidemia, therapeutic lifestyle modifications, drug therapy, and therapy adherence. 

The results of these trials demonstrate that ERT or HRT should not be prescribed for the prevention of CHD or in patients with preexisting CHD. For women suffering from vasomotor symptoms with a history of CHD, including CHD risk factors, alternative therapies should be considered. Additionally, lifestyle modifications should be implemented, and therapies to treat risk factors such as hypertension and hyperlipidemia should be prescribed. It is important to note that the average age of women included in the HERS and the WHI trials was 67 and 63 years, respectively. Therefore, these trials were unable to assess the true risk in younger, potentially healthier women with fewer cardiovascular risk factors. 

Hyperlipidemia All Pis (except ATV) Onset weeks to months after Underlying Use non-PI non-d4T-based Lifestyle modification switch to... 

---